FDA Advisory panel backs Arena's (ARNA) lorcaserin diet pill
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Join SI Premium – FREE
FDA Advisory panel backs Arena's (Nasdaq: ARNA), Eisai's lorcaserin diet pill
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Regeneron's Pasatru for rare bone disorder FOP
- Keenova doses first patient in Phase 3 hammer toe drug trial
- Alzamend Neuro fMRI data accepted for neuroscience conference poster
Create E-mail Alert Related Categories
FDA, Hot FDA NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
